Metal complexes are extensively used for cancer therapy. The multiple variables available
for tuning (metal, ligand, and metal–ligand interaction) offer unique opportunities for drug …

Curcumin, an active component of the rhizome turmeric, has gained much attention as a
plant-based compound with pleiotropic pharmacological properties. It possesses anti …

The concept of multi-action octahedral platinum (IV) complexes is based on the rational
derivatization of anticancer square-planar platinum (II) compounds (eg, cisplatin or …

For the first time, two new mononuclear platinum (II) coordination compounds,[Pt
(L1)(DMSO) Cl](PtL1) and [Pt (L2)(DMSO) Cl](PtL2) with the 5-(ethoxymethyl)-8 …

Curcumin (CUR) manifests anti-colon cancer activity but suffers from low solubility,
bioavailability, and instability, rendering it not as effective as its chemotherapeutic cousins …

Boron-dipyrromethene (BODIPY) based photosensitizers as porphyrinoids and curcumin as
natural product possess exciting photophysical features suitable for theranostic applications …

A platinum (IV) prodrug, cis, cis, trans-[Pt (NH3) 2Cl2 (biotin)(L)](1), derived from cisplatin,
where HL is the PEGylated red-light active boron-dipyrromethene (BODIPY) ligand, was …

[Pt (RB)(Cur)] NO3 (RBC),[Pt (IRB)(Cur)] NO3 (IRBC), and [Pt (L)(Cur)] NO3 (PBC), where
HCur is curcumin, L is 1-benzyl-2-(2-pyridyl) benzimidazole, and RB and IRB are red-light …

Octahedral Pt (IV) complexes (2Pt–R) containing a glycoconjugate carbene ligand were
prepared and fully characterized. These complexes are structural analogues to the trigonal …

The success story of cisplatin spans over six decades now and yet it continues to be the key
player in most chemotherapeutic regimens. Numerous efforts have been made to improve its …